Study title: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Harrison SA, Neuschwander Tetri BA. Clinics In Liver Disease 2004;8(4):861-879 2004;(4):861-879.Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Harrison SA, Neuschwander Tetri BA. Clinics In Liver Disease 2004;8(4):861-879 2004;(4):861-879.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Neoplasms [C04] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: TAMOXIFEN | |||||
ATC code: L02BA01 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |